相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。SMYD2 facilitates cancer cell malignancy and xenograft tumor development through ERBB2-mediated FUT4 expression in colon cancer
Yanzong Lai et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2022)
Actual Five-year Survival After Upfront Resection for Pancreatic Ductal Adenocarcinoma Who Beats the Odds?
Oliver Strobel et al.
ANNALS OF SURGERY (2022)
Cancer Statistics, 2021
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Identification of an epigenetic prognostic signature for patients with lower-grade gliomas
Hai Yu et al.
CNS NEUROSCIENCE & THERAPEUTICS (2021)
SMYD2 suppresses p53 activity to promote glucose metabolism in cervical cancer
Ying Wang et al.
EXPERIMENTAL CELL RESEARCH (2021)
Chromatin-Independent Interplay of NFATc1 and EZH2 in Pancreatic Cancer
Shilpa Patil et al.
CELLS (2021)
MAPK Activated Protein Kinase 3 Is a Prognostic-Related Biomarker and Associated With Immune Infiltrates in Glioma
Jing Ren et al.
FRONTIERS IN ONCOLOGY (2021)
SMYD2 promotes tumorigenesis and metastasis of lung adenocarcinoma through RPS7
Lei Wu et al.
CELL DEATH & DISEASE (2021)
Inhibition of bone morphogenetic protein receptor 2 suppresses pancreatic ductal adenocarcinoma growth by regulating GRB2/PI3K/AKT axis
Yazhou Wang et al.
ANNALS OF TRANSLATIONAL MEDICINE (2021)
ALK Rearrangement-Positive Pancreatic Cancer with Brain Metastasis Has Remarkable Response to ALK Inhibitors: A Case Report
Kai Ou et al.
FRONTIERS IN ONCOLOGY (2021)
Expression of the PTEN/FOXO3a/PLZF signalling pathway in pancreatic cancer and its significance in tumourigenesis and progression
Qiubo Zhang et al.
INVESTIGATIONAL NEW DRUGS (2020)
Analysis of the Substrate Specificity of the SMYD2 Protein Lysine Methyltransferase and Discovery of Novel Non-Histone Substrates
Sara Weirich et al.
CHEMBIOCHEM (2020)
Overexpression of SET and MYND domain-containing protein 2 (SMYD2) is associated with poor prognosis in pediatric B lineage acute lymphoblastic leukemia
Ping Zhang et al.
LEUKEMIA & LYMPHOMA (2020)
The lysine methyltransferase SMYD2 is required for normal lymphocyte development and survival of hematopoietic leukemias
Mark A. Brown et al.
GENES AND IMMUNITY (2020)
Validation of Novel Prognostic Biomarkers for Early-Stage Clear-Cell, Endometrioid and Mucinous Ovarian Carcinomas Using Immunohistochemistry
Hanna Engqvist et al.
FRONTIERS IN ONCOLOGY (2020)
Genomic and Epigenomic Landscaping Defines New Therapeutic Targets for Adenosquamous Carcinoma of the Pancreas
Elizabeth Lenkiewicz et al.
CANCER RESEARCH (2020)
κB-Ras and Ral GTPases regulate acinar to ductal metaplasia during pancreatic adenocarcinoma development and pancreatitis
Stephanie Beel et al.
NATURE COMMUNICATIONS (2020)
The histone methyltransferase SMYD2 is a novel therapeutic target for the induction of apoptosis in ovarian clear cell carcinoma cells
Machiko Kojima et al.
ONCOLOGY LETTERS (2020)
TRIM37 Mediates Chemoresistance and Maintenance of Stemness in Pancreatic Cancer Cells via Ubiquitination of PTEN and Activation of the AKT-GSK-3β-β-Catenin Signaling Pathway
Shiyu Chen et al.
FRONTIERS IN ONCOLOGY (2020)
Identification of an Immune-Related Gene Signature to Improve Prognosis Prediction in Colorectal Cancer Patients
Siqi Dai et al.
FRONTIERS IN GENETICS (2020)
Important roles of estrogen receptor alpha in tumor progression and anti-estrogen therapy of pancreatic ductal adenocarcinoma
Junsheng Xue et al.
LIFE SCIENCES (2020)
MTA2-mediated inhibition of PTEN leads to pancreatic ductal adenocarcinoma carcinogenicity
Wenzhe Si et al.
CELL DEATH & DISEASE (2019)
Expression patterns and the prognostic value of the SMYD family members in human breast carcinoma using integrative bioinformatics analysis
Jianping Song et al.
ONCOLOGY LETTERS (2019)
Small-molecule inhibitors of lysine methyltransferases SMYD2 and SMYD3: current trends
Edoardo Fabini et al.
FUTURE MEDICINAL CHEMISTRY (2019)
NMIIA promotes tumor growth and metastasis by activating the Wnt/β-catenin signaling pathway and EMT in pancreatic cancer
Pingting Zhou et al.
ONCOGENE (2019)
SMYD2-OE promotes oxaliplatin resistance in colon cancer through MDR1/P-glycoprotein via MEK/ERK/AP1 pathway
Hailiang Ren et al.
ONCOTARGETS AND THERAPY (2019)
Inhibition of SMYD2 Sensitized Cisplatin to Resistant Cells in NSCLC Through Activating p53 Pathway
Lei Shang et al.
FRONTIERS IN ONCOLOGY (2019)
Histone methyltransferase SMYD2: ubiquitous regulator of disease
Xin Yi et al.
CLINICAL EPIGENETICS (2019)
SMYD2 promotes cervical cancer growth by stimulating cell proliferation
Jun-Jie Sun et al.
CELL AND BIOSCIENCE (2019)
Regulation of EZH2 by SMYD2-Mediated Lysine Methylation Is Implicated in Tumorigenesis
Yi Zeng et al.
CELL REPORTS (2019)
Cytoplasmic PARP-1 promotes pancreatic cancer tumorigenesis and resistance
Fei Xu et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
The global, regional, and national burden of pancreatic cancer and its attributable risk factors in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017
Akram Pourshams et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2019)
Is MYND Domain-Mediated Assembly of SMYD3 Complexes Involved in Calcium Dependent Signaling?
Yingxue Zhang et al.
FRONTIERS IN MOLECULAR BIOSCIENCES (2019)
Tumor suppressor p53 and metabolism
Juan Liu et al.
JOURNAL OF MOLECULAR CELL BIOLOGY (2019)
KRAS: The Critical Driver and Therapeutic Target for Pancreatic Cancer
Andrew M. Waters et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2018)
Centrosomal Abnormalities in Pancreatic Cancer: Molecular Mechanisms and Clinical Implications
Daniel Ansari et al.
ANTICANCER RESEARCH (2018)
Small molecule inhibitors and CRISPR/Cas9 mutagenesis demonstrate that SMYD2 and SMYD3 activity are dispensable for autonomous cancer cell proliferation
Michael J. Thomenius et al.
PLOS ONE (2018)
Lysine methyltransferase SMYD2 promotes triple negative breast cancer progression
Linda Xiaoyan Li et al.
CELL DEATH & DISEASE (2018)
Positive Expression of SMYD2 is Associated with Poor Prognosis in Patients with Primary Hepatocellular Carcinoma
Shan-Ru Zuo et al.
JOURNAL OF CANCER (2018)
Overexpression of SET and MYND Domain-Containing Protein 2 (SMYD2) Is Associated with Tumor Progression and Poor Prognosis in Patients with Papillary Thyroid Carcinoma
Wenchao Xu et al.
MEDICAL SCIENCE MONITOR (2018)
CBX7 suppresses cell proliferation, migration, and invasion through the inhibition of PTEN/Akt signaling in pancreatic cancer
Sujie Ni et al.
ONCOTARGET (2017)
The lysine methyltransferase SMYD2 methylates the kinase domain of type II receptor BMPR2 and stimulates bone morphogenetic protein signaling
Shuman Gao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2017)
Critical roles of SMYD2-mediated β-catenin methylation for nuclear translocation and activation of Wnt signaling
Xiaolan Deng et al.
ONCOTARGET (2017)
Targeting the Akt/PI3K Signaling Pathway as a Potential Therapeutic Strategy for the Treatment of Pancreatic Cancer
Safieh Ebrahimi et al.
CURRENT MEDICINAL CHEMISTRY (2017)
Effects of SMYD2-mediated EML4-ALK methylation on the signaling pathway and growth in non-small-cell lung cancer cells
Rui Wang et al.
CANCER SCIENCE (2017)
Coordination of stress signals by the lysine methyltransferase SMYD2 promotes pancreatic cancer
Nicolas Reynoird et al.
GENES & DEVELOPMENT (2016)
SMYD2 overexpression is associated with tumor cell proliferation and a worse outcome in human papillomavirus-unrelated nonmultiple head and neck carcinomas
Rie Ohtomo-Oda et al.
HUMAN PATHOLOGY (2016)
Design, Synthesis, and Biological Activity of Substrate Competitive SMYD2 Inhibitors
Scott D. Cowen et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Discovery and Characterization of a Highly Potent and Selective Aminopyrazoline-Based in Vivo Probe (BAY-598) for the Protein Lysine Methyltransferase SMYD2
Erik Eggert et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
An Integrative Proteomic Approach Identifies Novel Cellular SMYD2 Substrates
Hazem Ahmed et al.
JOURNAL OF PROTEOME RESEARCH (2016)
Quantitative Profiling of the Activity of Protein Lysine Methyltransferase SMYD2 Using SILAC-Based Proteomics
Jonathan B. Olsen et al.
MOLECULAR & CELLULAR PROTEOMICS (2016)
Long-term survival in patients with pancreatic ductal adenocarcinoma
Alexander P. Stark et al.
SURGERY (2016)
Residual expression of SMYD2 and SMYD3 is associated with the acquisition of complex karyotype in chronic lymphocytic leukemia
Wilson Oliveira-Santos et al.
TUMOR BIOLOGY (2016)
Epidemiology of pancreatic cancer
Milena Ilic et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2016)
Upstream and Downstream Co-inhibition of Mitogen-Activated Protein Kinase and PI3K/Akt/mTOR Pathways in Pancreatic Ductal Adenocarcinoma
Matthew H. Wong et al.
NEOPLASIA (2016)
Expression of histone methyltransferases as novel biomarkers for renal cell tumor diagnosis and prognostication
Ana Silvia Pires-Luis et al.
EPIGENETICS (2015)
LLY-507, a Cell-active, Potent, and Selective Inhibitor of Protein-lysine Methyltransferase SMYD2
Hannah Nguyen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
Signaling pathway of MAPK/ERK in cell proliferation, differentiation, migration, senescence and apoptosis
Yu Sun et al.
JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION (2015)
Discovery of A-893, A New Cell-Active Benzoxazinone Inhibitor of Lysine Methyltransferase SMYD2
Ramzi F. Sweis et al.
ACS MEDICINAL CHEMISTRY LETTERS (2015)
Dysregulation of AKT Pathway by SMYD2-Mediated Lysine Methylation on PTEN
Makoto Nakakido et al.
NEOPLASIA (2015)
Overexpression of SMYD2 contributes to malignant outcome in gastric cancer
S. Komatsu et al.
BRITISH JOURNAL OF CANCER (2015)
SMYD2-dependent HSP90 methylation promotes cancer cell proliferation by regulating the chaperone complex formation
Ryuji Hamamoto et al.
CANCER LETTERS (2014)
Projecting Cancer Incidence and Deaths to 2030: The Unexpected Burden of Thyroid, Liver, and Pancreas Cancers in the United States
Lola Rahib et al.
CANCER RESEARCH (2014)
Structural Insights into Estrogen Receptor α Methylation by Histone Methyltransferase SMYD2, a Cellular Event Implicated in Estrogen Signaling Regulation
Yuanyuan Jiang et al.
JOURNAL OF MOLECULAR BIOLOGY (2014)
SMYD2 is highly expressed in pediatric acute lymphoblastic leukemia and constitutes a bad prognostic factor
Luis Henrique Toshihiro Sakamoto et al.
LEUKEMIA RESEARCH (2014)
Pancreatic Adenocarcinoma
David P. Ryan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
The Histone Methyltransferase SMYD2 Methylates PARP1 and Promotes Poly (ADP-ribosyl)ation Activity in Cancer Cells
Lianhua Piao et al.
NEOPLASIA (2014)
Genetic Alterations of K-ras, p53, c-erbB-2, and DPC4 in Pancreatic Ductal Adenocarcinoma and Their Correlation With Patient Survival
Sang Hyun Shin et al.
PANCREAS (2013)
Regulation of estrogen receptor a by histone methyltransferase SMYD2-mediated protein methylation
Xi Zhang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Pancreatic cancer: why is it so hard to treat?
Paul E. Oberstein et al.
THERAPEUTIC ADVANCES IN GASTROENTEROLOGY (2013)
Crosstalk of Sp1 and Stat3 signaling in pancreatic cancer pathogenesis
Chen Huang et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2012)
Hsp90 stabilizes Cdc25A and counteracts heat shock-mediated Cdc25A degradation and cell-cycle attenuation in pancreatic carcinoma cells
Benedikt Giessrigl et al.
HUMAN MOLECULAR GENETICS (2012)
MAMMALIAN MAPK SIGNAL TRANSDUCTION PATHWAYS ACTIVATED BY STRESS AND INFLAMMATION: A 10-YEAR UPDATE
John M. Kyriakis et al.
PHYSIOLOGICAL REVIEWS (2012)
Pancreatic ductal adenocarcinoma: Long-term survival does not equal cure
Cristina R. Ferrone et al.
SURGERY (2012)
RB1 Methylation by SMYD2 Enhances Cell Cycle Progression through an Increase of RB1 Phosphorylation
Hyun-Soo Cho et al.
NEOPLASIA (2012)
Deletion of Rb Accelerates Pancreatic Carcinogenesis by Oncogenic Kras and Impairs Senescence in Premalignant Lesions
Catherine Carriere et al.
GASTROENTEROLOGY (2011)
The JAK2/STAT3 signaling pathway is required for growth of CD44+CD24- stem cell-like breast cancer cells in human tumors
Lauren L. C. Marotta et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Structural Basis of Substrate Methylation and Inhibition of SMYD2
Andrew D. Ferguson et al.
STRUCTURE (2011)
MAPKAP kinases MK2 and MK3 in inflammation: Complex regulation of TNF biosynthesis via expression and phosphorylation of tristetraprolin
Natalia Ronkina et al.
BIOCHEMICAL PHARMACOLOGY (2010)
Mitogen-activated protein kinase p38 and MK2, MK3 and MK5: Menage a trois or menage a quatre?
Alexey Shiryaev et al.
CELLULAR SIGNALLING (2010)
Methylation of the Retinoblastoma Tumor Suppressor by SMYD2
Louis A. Saddic et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
IGF-1 Mediates PTEN Suppression and Enhances Cell Invasion and Proliferation via Activation of the IGF-1/PI3K/Akt Signaling Pathway in Pancreatic Cancer Cells
Jiachi Ma et al.
JOURNAL OF SURGICAL RESEARCH (2010)
Advanced pancreatic carcinoma: current treatment and future challenges
Anastasios Stathis et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2010)
Mutant p53 Gain-of-Function in Cancer
Moshe Oren et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2010)
Methylation Patterns of Rb1 and Casp-8 Promoters and Their Impact on Their Expression in Bladder Cancer
Kianoosh Malekzadeh et al.
CANCER INVESTIGATION (2009)
Overexpression of SMYD2 relates to tumor cell proliferation and malignant outcome of esophageal squamous cell carcinoma
Shuhei Komatsu et al.
CARCINOGENESIS (2009)
PTEN regulate angiogenesis through PI3K/Akt/VEGF signaling pathway in human pancreatic cancer cells
Jiachi Ma et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2009)
The tale of two domains - Proteomics and genomics analysis of SMYD2, a new histone methyltransferase
Mohamed Abu-Farha et al.
MOLECULAR & CELLULAR PROTEOMICS (2008)
RAS/ERK modulates TGFβ-regulated PTEN expression in human pancreatic adenocarcinoma cells
Jimmy Y. C. Chow et al.
CARCINOGENESIS (2007)
AKT/PKB signaling: Navigating downstream
Brendan D. Manning et al.
CELL (2007)
Repression of p53 activity by Smyd2-mediated methylation
Jing Huang et al.
NATURE (2006)
Gadd45a suppresses ras-driven mammary tumorigenesis by activation of c-Jun NH2-terminal kinase and p38 stress signaling resulting in apoptosis and senescence
Jennifer S. Tront et al.
CANCER RESEARCH (2006)
Identification and characterization of Smyd2: a split SET/MYND domain-containing histone H3 lysine 36-specific methyltransferase that interacts with the Sin3 histone deacetylase complex
Mark A. Brown et al.
MOLECULAR CANCER (2006)
The PI 3-kinase/Akt signaling pathway is activated due to aberrant Pten expression and targets transcription factors NF-κB and c-Myc in pancreatic cancer cells
T Asano et al.
ONCOGENE (2004)
Decision making by p53: life, death and cancer
M Oren
CELL DEATH AND DIFFERENTIATION (2003)
Expression of p57kip2, Rb protein and PCNA and their relationships with clinicopathology in human pancreatic cancer
H Yue et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2003)
Histone lysine methylation: a signature for chromatin function
RJ Sims et al.
TRENDS IN GENETICS (2003)
分享论文
